Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: A prospective observational safety study

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2810-2817

  Slobbe, Lennert ^a   Waal, Loes van der ^a   Jongman, Lydia R ^a   Lugtenburg, Pieternella J ^a   Rijnders, Bart J A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fluoroquinolone and fluconazole prophylaxis; Haematology; Neutropaenic fever; Short term empirical antibiotics; Unexplained fever

Indexed keywords

AMIKACIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; CYTARABINE; ETOPOSIDE; FLUCONAZOLE; IMIPENEM; METHOTREXATE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; CLINICAL EVALUATION; CLINICAL TRIAL; COLLOID; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NEUTROPENIA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPTIC SHOCK; TERTIARY HEALTH CARE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; COLISTIN; DRUG THERAPY, COMBINATION; FEMALE; FEVER OF UNKNOWN ORIGIN; FLUCONAZOLE; FLUOROQUINOLONES; HEMATOLOGIC NEOPLASMS; HUMANS; IMIPENEM; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 70350100717     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.06.025     Document Type: Article

References (24)

1. Antoniadou A., and Giamarellou H. Fever of unknown origin in febrile leukopenia. Infect Dis Clin North Am 21 (2007) 1055-1090 x
2. Bodey G.P., Buckley M., Sathe Y.S., et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64 (1966) 328-340
3. Neuburger S., and Maschmeyer G. Update on management of infections in cancer and stem cell transplant patients. Ann Hematol 85 (2006) 345-356
4. Viscoli C., and Castagnola E. Planned progressive antimicrobial therapy in neutropenic patients. Br J Haematol 102 (1998) 879-888
5. Viscoli C., Varnier O., and Machetti M. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. Clin Infect Dis 40 Suppl. 4 (2005) S240-S245
6. Hughes W.T., Armstrong D., Bodey G.P., et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34 (2002) 730-751
7. Viscoli C., and Castagnola E. Treatment of febrile neutropenia: what is new?. Curr Opin Infect Dis 15 (2002) 377-382
8. Wisplinghoff H., Seifert H., Wenzel R.P., et al. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36 (2003) 1103-1110
9. Bucaneve G., Micozzi A., Menichetti F., et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. New Engl J Med 353 (2005) 977-987
10. Clasener H.A., Vollaard E.J., and van Saene H.K. Long-term prophylaxis of infection by selective decontamination in leukopenia and in mechanical ventilation. Rev Infect Dis 9 (1987) 295-328
11. Cullen M., Steven N., Billingham L., et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. New Engl J Med 353 (2005) 988-998
12. Imran H., Tleyjeh I.M., Arndt C.A., et al. Fluoroquinolone prophylaxis in patients with neutropenia: a meta-analysis of randomized placebo-controlled trials. Eur J Clin Microbiol Infect Dis 27 (2008) 53-63
13. Sleijfer D.T., Mulder N.H., de Vries-Hospers H.G., et al. Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer 16 (1980) 859-869
14. Gafter-Gvili A., Fraser A., Paul M., et al. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 142 (2005) 979-995
15. de Marie S., van den Broek P.J., Willemze R., et al. Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination. Eur J Clin Microbiol Infect Dis 12 (1993) 897-906
16. Joshi J.H., Schimpff S.C., Tenney J.H., et al. Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?. Am J Med 76 (1984) 450-457
17. Klastersky J.A. Use of imipenem as empirical treatment of febrile neutropenia. Int J Antimicrob Agents 21 (2003) 393-402
18. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 (2001) 1249-1272
19. De Pauw B., Walsh T.J., Donnelly J.P., et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46 (2008) 1813-1821
20. Cometta A., Kern W.V., De Bock R., et al. Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy. Clin Infect Dis 37 (2003) 382-389
21. Maertens J., Huysmans G., and Theunissen K. Early diagnosis and preemptive therapy of pulmonary mold infections in high-risk patients. Curr Infect Dis Rep 10 (2008) 459-465
22. Maertens J., Theunissen K., Verhoef G., et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 41 (2005) 1242-1250
23. Oshima K., Kanda Y., Asano-Mori Y., et al. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients. J Antimicrob Chemother 60 (2007) 350-355
24. Slobbe L., Polinder S., Doorduijn J.K., et al. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study. Clin Infect Dis 47 (2008) 1507-1512